Single‑incision da Vinci SP robotic surgical staging for endometrial cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, multicenter observational project that will consecutively enroll patients with endometrial cancer who undergo robotic staging using the da Vinci SP platform. Procedures include hysterectomy with bilateral salpingo‑oophorectomy (with ovarian preservation allowed in selected cases) and possible sentinel lymph node biopsy or pelvic/para‑aortic lymphadenectomy as clinically indicated. The study will record perioperative metrics such as operative time, blood loss, conversion rates, complications, and early oncologic and recovery outcomes. No experimental treatment is assigned; data will be collected to document feasibility, safety, and early performance of the single‑port robotic approach.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥ 18 years
* Histologically confirmed endometrial carcinoma (including uterine carcinosarcoma)
* Performance status (ECOG) 0 - 1
* Patients undergoing staging surgery for endometrial cancer, including but not limited to robotic hysterectomy with bilateral salpingo-oophorectomy (ovarian preservation in selected patients is not an exclusion criterion) and possible sentinel lymph node biopsy/pelvic ± para-aortic lymphadenectomy
* Signed informed consent to participate in the study

Exclusion Criteria:

* Patients scheduled for an additional extra-genital surgical procedure during the staging surgery for endometrial carcinoma
* Patients with anesthesiological contraindications to a minimally invasive approach
* Synchronous tumor
* Recurrence of endometrial carcinoma
* Dementia or significantly altered mental status that may impair understanding and the ability to provide informed consent
* Any reason that may interfere with regular follow-up, even if limited to the first 30 days post-surgery

Where it's running

• Istituto Nazionale Tumori | "Fondazione Pascale"
  Naples, Napoli, Italy Recruiting
• IEO - Istituto Europeo di Oncologia
  Milan, Italy Recruiting
• Istituti Fisioterapici Ospitalieri - IFO
  Roma, Italy Recruiting

Study contacts

• Principal investigator: Vito Chiantera, MD — IRCCS I.N.T. "G. Pascale"
• Study coordinator: Giuseppe Cucinella, MD
• Email: giuseppe.cucinella@istitutotumori.na.it
• Phone: 00000000000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Personalized navigation to support rural and Black women with endometrial cancer

  This pilot tests a tailored patient-navigation program to help rural and Black patients with endometrial cancer access care and services.

  Recruiting UNC Lineberger Comprehensive Cancer Center · Chapel Hill, North Carolina · NCT07927244

• CR-002 study in adults with advanced solid tumors

  This trial tests CR-002 as a single therapy to see if it is safe and tolerable in adults with locally advanced or metastatic solid tumors

  Recruiting at 3 sites Phase 1/2 Crescent Biopharma, Inc. · Austin, Texas and 2 other locations · NCT07909031

• Methylation markers in self-samples to help detect gynecological cancers

  This study tests whether self-collected urine and vaginal samples can reveal DNA methylation or other genetic markers that indicate endometrial, ovarian, vulvar, or vaginal cancers in women who are at risk or have postmenopausal bleeding.

  Recruiting Universiteit Antwerpen · Edegem, Antwerp · NCT07902375

• One-Finger Technique to identify the left upper ureter during para-aortic lymphadenectomy

  This study tests a new surgical method to help surgeons find the left upper ureter during open para-aortic lymphadenectomy in women with gynecologic cancers.

  Recruiting Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Guangzhou, Guangdong · NCT07895212

• Liquid biopsy screening for early endometrial cancer in regional China

  A non-invasive blood test using cell-free DNA is being tested to see if it can detect early endometrial cancer and tell apart benign from malignant uterine lesions.

  Recruiting Guizhou Provincial People's Hospital · Guiyang, Guizhou · NCT07892755

• Radiotherapy for gynecologic cancer with up to 10 metastatic sites

  This registry follows adults with gynecologic cancer who have 1 to 10 active metastatic lesions and are treated with radiotherapy as part of routine care to see how such treatments work in real-world settings.

  Recruiting Affidea Nu-med Center of Oncological DIagnostics and Therapy · Zamość · NCT07883798

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.